A reference catalogue. Each entry contains structural data, mechanism, primary literature, regulatory cross-reference, and our independent evidence grade. We never accept payment from manufacturers or sellers.
| # | Compound | Category | Evidence | EU Status | Last reviewed |
|---|---|---|---|---|---|
| 001. | 5-Amino-1MQ | Metabolic NNMT (nicotinamide N-methyltransferase) inhibitor · investigational metabolic modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 002. | AOD-9604 | Metabolic Synthetic fragment of HGH (residues 176-191) · purported lipolytic agent | D | NOT AUTHORISED | 18 MAY 2026 |
| 003. | ARA-290 INN · cibinetidum | Recovery 11-AA EPO-derived peptide · innate-repair receptor agonist · non-erythropoietic | C | NOT AUTHORISED | 18 MAY 2026 |
| 004. | BPC-157 C₆₂H₉₈N₁₆O₂₂ · MW 1419.5 | Recovery Synthetic pentadecapeptide fragment of human gastric juice BPC · investigational | C | NOT AUTHORISED | 18 MAY 2026 |
| 005. | Bremelanotide INN · bremelanotidum | Hormonal Melanocortin (MC1R/MC3R/MC4R) receptor agonist · on-demand subcutaneous | A | NOT AUTHORISED | 18 MAY 2026 |
| 006. | Bronchogen | Recovery Short peptide bioregulator · claimed bronchial tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 007. | Cagrilintide INN · cagrilintidum | Metabolic Long-acting amylin receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 008. | Chonluten | Recovery Short peptide bioregulator · claimed bronchopulmonary tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 009. | CJC-1295 | Hormonal Modified GHRH analogue (29 AA) · prolonged GH release · grey-market protocols add DAC linker | D | NOT AUTHORISED | 18 MAY 2026 |
| 010. | Cortagen | Cognitive Short peptide bioregulator · claimed cortical tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 011. | Cotadutide INN · cotadutidum | Metabolic Dual GLP-1 / glucagon receptor agonist · investigational, development paused | C | NOT AUTHORISED | 18 MAY 2026 |
| 012. | Dihexa | Cognitive Angiotensin-IV analogue · claimed HGF/c-Met activator · oral bioavailability | D | NOT AUTHORISED | 18 MAY 2026 |
| 013. | DSIP Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | Cognitive Delta Sleep-Inducing Peptide · 9-AA nonapeptide · putative sleep / stress modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 014. | Epitalon C₁₄H₂₂N₄O₉ · MW 390.4 | Longevity Synthetic tetrapeptide · claimed pineal regulator and telomerase activator | D | NOT AUTHORISED | 18 MAY 2026 |
| 015. | FOX04-DRI | Longevity D-retro-inverso peptide · disrupts FOXO4-p53 interaction · senolytic | D | NOT AUTHORISED | 18 MAY 2026 |
| 016. | GHK-Cu C₁₄H₂₃CuN₆O₄ · MW 405 | Cosmetic Copper-bound tripeptide · skin-barrier modulator, wound-healing adjunct | B | AUTHORISED | 18 MAY 2026 |
| 017. | GHRP-2 D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ | Hormonal Synthetic hexapeptide ghrelin-receptor agonist · pulsatile GH release | C | NOT AUTHORISED | 18 MAY 2026 |
| 018. | GHRP-6 His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ | Hormonal Synthetic hexapeptide ghrelin-receptor agonist · GH release + appetite stimulation | C | NOT AUTHORISED | 18 MAY 2026 |
| 019. | Hexarelin His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂ | Hormonal Synthetic hexapeptide ghrelin-receptor agonist · GH-releasing + cardioactive | C | NOT AUTHORISED | 18 MAY 2026 |
| 020. | Humanin Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala | Longevity 24-AA mitochondrial-derived peptide · cytoprotective signalling | D | NOT AUTHORISED | 18 MAY 2026 |
| 021. | IGF-1 LR3 | Hormonal Modified insulin-like growth factor 1 · long Arg3 substitution increases serum half-life | D | NOT AUTHORISED | 18 MAY 2026 |
| 022. | Ipamorelin C₃₈H₄₉N₉O₅ · MW 711.9 | Hormonal Selective ghrelin-receptor agonist (GHRP) · pulsatile GH release | D | NOT AUTHORISED | 18 MAY 2026 |
| 023. | Kisspeptin-10 Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ | Hormonal C-terminal decapeptide of kisspeptin · GPR54 agonist · stimulates GnRH release | C | NOT AUTHORISED | 18 MAY 2026 |
| 024. | KPV Lys-Pro-Val | Recovery C-terminal tripeptide of α-MSH · anti-inflammatory, anti-microbial | D | NOT AUTHORISED | 18 MAY 2026 |
| 025. | Livagen Lys-Glu-Asp-Ala | Longevity Tetrapeptide bioregulator · claimed hepatic tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 026. | LL-37 | Recovery Cathelicidin-derived antimicrobial peptide · 37 residues · broad-spectrum | C | NOT AUTHORISED | 18 MAY 2026 |
| 027. | Matrixyl 3000 INN · palmitoyl-tripeptide-1 | Cosmetic Palmitoyl tripeptide-1 + tetrapeptide-7 · topical matrikine, MMP modulator | B | AUTHORISED | 18 MAY 2026 |
| 028. | Mazdutide INN · mazdutidum | Metabolic Dual GLP-1 / glucagon receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 029. | Melanotan II C₅₀H₆₉N₁₅O₉ · MW 1024.2 | Hormonal Cyclic heptapeptide · non-selective melanocortin receptor agonist | F | PROHIBITED | 18 MAY 2026 |
| 030. | Melanotan-I INN · afamelanotidum | Hormonal Cyclic heptapeptide · selective α-MSH analogue · MC1R-preferential | B | AUTHORISED | 18 MAY 2026 |
| 031. | MOTS-c Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg | Longevity 16-AA mitochondrial-derived peptide · metabolic regulator (AMPK pathway) | D | NOT AUTHORISED | 18 MAY 2026 |
| 032. | Normoftal | Cognitive Short peptide bioregulator · claimed retinal tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 033. | Ovagen | Hormonal Short peptide bioregulator · claimed ovarian / hepatic tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 034. | Oxytocin INN · oxytocinum · C₄₃H₆₆N₁₂O₁₂S₂ · MW 1007.2 | Hormonal Endogenous nonapeptide hormone · uterine smooth-muscle contraction, milk let-down | S | AUTHORISED | 18 MAY 2026 |
| 035. | P21 | Cognitive Synthetic CNTF-derived peptide · claimed neurogenesis enhancer | D | NOT AUTHORISED | 18 MAY 2026 |
| 036. | Pancragen | Metabolic Short peptide bioregulator · claimed pancreatic tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 037. | Pinealon Glu-Asp-Arg | Cognitive Tripeptide bioregulator · claimed pineal gland modulator and neuroprotective | D | NOT AUTHORISED | 18 MAY 2026 |
| 038. | PNC27 | Recovery HDM-2 binding domain of p53 fused to membrane-residency peptide · cancer-selective lytic | D | NOT AUTHORISED | 18 MAY 2026 |
| 039. | Prostamax | Hormonal Short peptide bioregulator · claimed prostatic tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 040. | Retatrutide INN · retatrutidum | Metabolic Triple GLP-1 / GIP / glucagon receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 041. | Selank C₃₃H₅₇N₁₁O₉ · MW 751.9 | Cognitive Synthetic heptapeptide · tuftsin analogue · claimed anxiolytic + nootropic | C | NOT AUTHORISED | 18 MAY 2026 |
| 042. | Semaglutide INN · semaglutidum · C₁₈₇H₂₉₁N₄₅O₅₉ · MW 4113.6 | Metabolic GLP-1 receptor agonist · once-weekly subcutaneous | S | AUTHORISED | 18 MAY 2026 |
| 043. | Semax Met-Glu-His-Phe-Pro-Gly-Pro | Cognitive Synthetic ACTH(4-7) analogue · claimed neuroprotective + nootropic | C | NOT AUTHORISED | 18 MAY 2026 |
| 044. | Sermorelin INN · sermorelinum | Hormonal Synthetic GHRH(1-29) analogue · stimulates pulsatile GH release · daily subcutaneous | C | NOT AUTHORISED | 18 MAY 2026 |
| 045. | Setmelanotide INN · setmelanotidum | Hormonal MC4R-selective melanocortin receptor agonist · daily subcutaneous | A | AUTHORISED | 18 MAY 2026 |
| 046. | SLU-PP-332 | Metabolic ERR (estrogen-related receptor) pan-agonist · investigational exercise-mimetic | D | NOT AUTHORISED | 18 MAY 2026 |
| 047. | SNAP-8 INN · acetyl-octapeptide-3 | Cosmetic Acetyl octapeptide-3 · topical SNARE-complex modulator · "Botox-like" wrinkle claim | C | AUTHORISED | 18 MAY 2026 |
| 048. | SS-31 INN · elamipretidum | Longevity Cell-permeable tetrapeptide · cardiolipin-binding · mitochondrial-targeted | B | NOT AUTHORISED | 18 MAY 2026 |
| 049. | Survodutide INN · survodutidum | Metabolic Dual GLP-1 / glucagon receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 050. | TB-500 | Recovery Synthetic fragment of thymosin beta-4 · purported actin-binding, angiogenic, regenerative | D | NOT AUTHORISED | 18 MAY 2026 |
| 051. | Tesamorelin INN · tesamorelinum | Metabolic Synthetic GHRH analogue · stimulates pituitary GH release · daily subcutaneous | A | AUTHORISED | 18 MAY 2026 |
| 052. | Testagen Lys-Glu-Asp-Gly | Hormonal Tetrapeptide bioregulator · claimed testicular tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 053. | Thymalin | Recovery Polypeptide complex extracted from calf thymus · claimed immunomodulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 054. | Thymogen Glu-Trp | Recovery Dipeptide bioregulator · claimed thymic / immune modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 055. | Thymosin alpha-1 INN · thymalfasinum | Recovery Acetylated 28-AA peptide · immunomodulator · enhances T-cell maturation | B | NOT AUTHORISED | 18 MAY 2026 |
| 056. | Tirzepatide INN · tirzepatidum · C₂₂₅H₃₄₈N₄₈O₆₈ · MW 4813.5 | Metabolic Dual GIP / GLP-1 receptor agonist · once-weekly subcutaneous | S | AUTHORISED | 18 MAY 2026 |
| 057. | Vesilute | Hormonal Short peptide bioregulator · claimed bladder tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 058. | Vilon Lys-Glu | Longevity Dipeptide bioregulator · claimed thymic / immune modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 059. | VIP | Hormonal Vasoactive Intestinal Peptide · 28-AA endogenous neuropeptide · VPAC1/VPAC2 receptors | C | NOT AUTHORISED | 18 MAY 2026 |
| No matches. Clear the search or filter. | |||||